Home / Clinical Resources / Genital Warts (HPV): Prevention, Clinical Features & Therapies

Genital Warts (HPV): Prevention, Clinical Features & Therapies

Clinical overview of genital warts (HPV): Gardasil 9 vaccination impact, visual diagnosis, patient-applied creams, and procedural treatments.

Pathogenesis & Transmission

Genital warts (condylomata acuminata) are benign epidermal proliferations of the skin and mucous membranes of the anogenital region caused by low-risk types of the Human Papillomavirus (predominantly HPV 6 and 11). They do not cause cervical, penile, or anal cancer.

HPV is transmitted through direct skin-to-skin contact during vaginal, anal, or oral sexual activity. Micro-abrasions in the epithelial surface allow virions to access the basal layer of keratinocytes. The incubation period is highly variable, ranging from 3 weeks to several months or years after exposure.

Clinical Appearance & Diagnosis

Diagnosis is based primarily on clinical visual inspection under good lighting. Routine biopsy is rarely required unless lesions are atypical, pigmented, ulcerated, or refractory to standard therapy.

Warts present in several morphological forms:

  • Cauliflower-like: Exophytic, flesh-coloured or pink sessile or pedunculated papillomas.
  • Flat: Smooth, slightly elevated papules often visible on the penile shaft or labia minora.
  • Keratotic: Hard, hyperkeratotic lesions resembling cutaneous warts, common on dry keratinised skin (scrotum, pubic area).

Treatment Options: Patient-Applied vs Clinician-Administered

The goal of treatment is the physical elimination of visible warts and symptomatic relief. Treatment does not completely eradicate the underlying viral genome; the host immune system clears the virus over time (typically within 12 to 24 months):

  • Patient-Applied Therapies (for soft, non-keratinised lesions):
    • Podophyllotoxin 0.5% solution/cream: Antimitotic agent applied twice daily for 3 consecutive days, followed by 4 rest days, repeated weekly for up to 4 cycles. (Contraindicated in pregnancy).
    • Imiquimod 5% cream: Immune response modifier that stimulates local interferon and cytokine production. Applied three times weekly at bedtime (washed off after 6–10 hours) for up to 16 weeks.
  • Clinician-Administered Procedural Therapies:
    • Cryotherapy (Liquid Nitrogen): Controlled freeze-thaw cycles using a cryo-spray or probe every 1 to 2 weeks. Safe and preferred during pregnancy.
    • Trichloroacetic Acid (TCA 80–90%): Chemical caustic agent applied precisely to lesions until white frosting appears. Safe in pregnancy.
    • Surgical Excision or Diathermy: Reserved for extensive, bulky, or obstructing perianal or vulval lesions.

Psychosexual Reassurance & Counselling

A diagnosis of genital warts frequently causes significant shame, distress, and anxiety regarding past relationships. Clinicians provide clear reassurance: HPV is a ubiquitous human virus, having warts does not impact fertility, and natural host immunity effectively clears the clinical manifestation over time.

Archival Document Available: You can also access Dr Tseng's original reference sheet as a printable PDF.
Download Original PDF
Authored by Dr Jimmy Tseng
BMedSci, MBBS, PGDipSurgAnat, GCUT, FRACGP • Specialist GP, Founder & Senior Lecturer
Explore 24+ Clinical Resources ↗